146 related articles for article (PubMed ID: 4353274)
1. Inactivation of melanocyte-stimulating hormone release-inhibiting factor by a manganese-stimulated bovine brain aminopeptidase.
Simmons WH; Brecher AS
J Biol Chem; 1973 Aug; 248(16):5780-4. PubMed ID: 4353274
[No Abstract] [Full Text] [Related]
2. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
Castensson S; Sievertsson H; Lindeke B; Sum CY
FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370
[No Abstract] [Full Text] [Related]
3. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
Deslauriers R; Walter R; Smith IC
Biochem Biophys Res Commun; 1973 Jul; 53(1):244-50. PubMed ID: 4354931
[No Abstract] [Full Text] [Related]
4. Carbon-13 NMR studies of peptide hormones and their components.
Smith IC; Deslauriers R; Saitô H; Walter R; Garrigou-Lagrange C; McGregor H; Sarantakis D
Ann N Y Acad Sci; 1973 Dec; 222():597-627. PubMed ID: 4361873
[No Abstract] [Full Text] [Related]
5. MSH-release-inhibiting factor: inactivation by proteolytic enzymes.
Marks N; Walter R
Proc Soc Exp Biol Med; 1972 Jun; 140(2):673-6. PubMed ID: 4338802
[No Abstract] [Full Text] [Related]
6. Hypothalamic releasing factors and Parkinson disease.
Chase TN; Woods AC; Lipton MA; Morris CE
Arch Neurol; 1974 Jul; 31(1):55-6. PubMed ID: 4209275
[No Abstract] [Full Text] [Related]
7. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation.
Walter R; Griffiths EC; Hooper KC
Brain Res; 1973 Oct; 60(2):449-57. PubMed ID: 4587290
[No Abstract] [Full Text] [Related]
8. Chemistry of the hypothalamic releasing factors--studies on structure-function relationships.
Vale W; Grant G; Guillemin R
Front Neuroendocrinol; 1973; 0(0):375-413. PubMed ID: 4369859
[No Abstract] [Full Text] [Related]
9. Conformational mobility of the pyrrolidine ring of proline in peptides and peptide hormones as manifest in carbon 13 spin-lattice relaxation times.
Deslauriers R; Smith IC; Walter R
J Biol Chem; 1974 Nov; 249(21):7006-10. PubMed ID: 4371430
[No Abstract] [Full Text] [Related]
10. General activity in intact and hypophysectomized rats after administration of melanocyte-stimulating hormone (MSH), melatonin, and PRO-LEU-GLY-NH 2 .
Kastin AJ; Miller MC; Ferrell L; Schally AV
Physiol Behav; 1973 Feb; 10(2):399-401. PubMed ID: 4575310
[No Abstract] [Full Text] [Related]
11. MSH-release inhibiting factors: recent studies.
Kastin AJ; Plotnikoff NP; Viosca S; Anderson MS; Schally AV
Yale J Biol Med; 1973 Dec; 46(5):617-22. PubMed ID: 4591788
[No Abstract] [Full Text] [Related]
12. Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.
Huidobro-Toro JP; De Carolis AS; Longo VG
Pharmacol Biochem Behav; 1974; 2(1):105-9. PubMed ID: 4364044
[No Abstract] [Full Text] [Related]
13. Behavioral effects of thyrotropin releasing hormone in animals and man: a generic hypothesis.
Prange AJ; Wilson IC
Psychopharmacol Bull; 1975 Jan; 11(1):22-4. PubMed ID: 804704
[No Abstract] [Full Text] [Related]
14. [Progress in the study of hypothalamic hormones].
Ito T
Horumon To Rinsho; 1975 Jan; 23(1):1-5. PubMed ID: 168014
[No Abstract] [Full Text] [Related]
15. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma.
Nair RM; Redding TW; Kastin AJ; Schally AV
Biochem Pharmacol; 1973 Aug; 22(15):1915-9. PubMed ID: 4578947
[No Abstract] [Full Text] [Related]
16. Structure-activity studies of MSH-release-inhibiting hormone.
Celis ME; Hase S; Walter R
FEBS Lett; 1972 Nov; 27(2):327-30. PubMed ID: 4352026
[No Abstract] [Full Text] [Related]
17. Isolation and structure of hypothalamic MSH release-inhibition hormone.
Nair RM; Kastin AJ; Schally AV
Biochem Biophys Res Commun; 1971 Jun; 43(6):1376-81. PubMed ID: 4398196
[No Abstract] [Full Text] [Related]
18. Peptidase inactivation of hypothalamic releasing hormones.
Griffiths EC
Horm Res; 1976; 7(3):179-91. PubMed ID: 12075
[TBL] [Abstract][Full Text] [Related]
19. Prolyl aminopeptidase from rat brain and kidney. Action on peptides and identification as leucyl aminopeptidase.
Turzynski A; Mentlein R
Eur J Biochem; 1990 Jul; 190(3):509-15. PubMed ID: 2373079
[TBL] [Abstract][Full Text] [Related]
20. The present concept of the nature of hypothalamic hormones stimulating and inhibiting the release of pituitary hormones.
Schally AV; Kastin AJ
Triangle; 1969; 9(1):19-25. PubMed ID: 4980829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
